These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

318 related articles for article (PubMed ID: 6767279)

  • 21. Locally advanced uterine cervical cancer: our experience on 102 cases.
    Montemaggi P; Falcinelli R; Bambace S; Guerrieri P; Villani L; Nardone L; Cellini N
    Rays; 1986; 11(2):115-8. PubMed ID: 3110867
    [No Abstract]   [Full Text] [Related]  

  • 22. [Malignancy of the uterine body after radiotherapy for carcinoma of uterine cervix--report of 12 cases].
    Yu GR
    Zhonghua Zhong Liu Za Zhi; 1985 Sep; 7(5):361-3. PubMed ID: 3004856
    [TBL] [Abstract][Full Text] [Related]  

  • 23. [Radiotherapy of cervix cancer--treatment results and intestinal side effects].
    Grimm D; Glaser FH; Heider KM; Salewski D
    Radiobiol Radiother (Berl); 1984; 25(2):263-71. PubMed ID: 6739769
    [No Abstract]   [Full Text] [Related]  

  • 24. [Radiation therapy for cervix cancer].
    Arai T
    Rinsho Hoshasen; 1984 May; 29(5):643-4. PubMed ID: 6482045
    [No Abstract]   [Full Text] [Related]  

  • 25. Radiotherapy for uterine cervical cancer: results of the 1995-1997 patterns of care process survey in Japan.
    Toita T; Nakamura K; Uno T; Kodaira T; Shinoda A; Ogawa K; Mitsuhashi N; Maebayashi K; Kawaguchi A; Inoue T; Teshima T
    Jpn J Clin Oncol; 2005 Mar; 35(3):139-48. PubMed ID: 15741304
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Late complications of radiation-induced damage to the gastro-intestinal tract.
    Wolloch Y; Chaimoff C; Dintsman M
    Am J Proctol; 1973 Dec; 24(6):473-80. PubMed ID: 4770682
    [No Abstract]   [Full Text] [Related]  

  • 27. Radiotherapy.
    Prosnitz LR; Kapp DS; Weissberg JB
    N Engl J Med; 1983 Oct; 309(14):834-40. PubMed ID: 6412141
    [No Abstract]   [Full Text] [Related]  

  • 28. High dose rate intracavitary sources in the treatment of cancer of the uterus.
    Merkas Z
    Radiobiol Radiother (Berl); 1976; 17(4):473-82. PubMed ID: 1005678
    [No Abstract]   [Full Text] [Related]  

  • 29. Therapeutic outcome and prognostic factors in the radiotherapy of recurrences of cervical carcinoma following surgery.
    Hille A; Weiss E; Hess CF
    Strahlenther Onkol; 2003 Nov; 179(11):742-7. PubMed ID: 14605743
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Patterns of pain and distress during high-dose-rate intracavity brachytherapy for cervical cancer.
    Kwekkeboom KL; Dendaas NR; Straub M; Bradley KA
    J Support Oncol; 2009; 7(3):108-14. PubMed ID: 19507459
    [TBL] [Abstract][Full Text] [Related]  

  • 31. [Stage related radiation treatment of endometrial cancer].
    Müller RP; Schnepper E; Fischedick AR
    Med Welt; 1983 Jan; 34(2):48-50. PubMed ID: 6827958
    [No Abstract]   [Full Text] [Related]  

  • 32. Radiation-induced early changes in size and vascularity of cervical carcinoma. A colpophotographic and clinical study.
    Bergsjo P
    Acta Radiol Diagn (Stockh); 1967; ():Suppl 274:7+. PubMed ID: 5617058
    [No Abstract]   [Full Text] [Related]  

  • 33. Oxygen tension of cervical carcinoma during the early phase of external irradiation. I. Measurements with a Clark micro electrode.
    Bergsjo P; Evans JC
    Scand J Clin Lab Invest Suppl; 1968; 106():159-66. PubMed ID: 5731702
    [No Abstract]   [Full Text] [Related]  

  • 34. The effects of radiation upon the cytology of benign and malignant bladder epithelia.
    Loveless KJ
    Acta Cytol; 1973; 17(4):355-60. PubMed ID: 4516233
    [No Abstract]   [Full Text] [Related]  

  • 35. The relationship of NSD to reactions and complications following treatment for malignant uterine cervical neoplasms.
    Buchler DA; Kline JC; Peckham BM; Ellis F
    Radiology; 1974 Mar; 110(3):687-90. PubMed ID: 4204517
    [No Abstract]   [Full Text] [Related]  

  • 36. [Evaluation of the effectiveness of high voltage irradiation of malignant gynecologic tumors in a nude mouse model].
    Stange S; Kleine W; Ladner HA; Schwantes H
    Strahlentherapie; 1982 Dec; 158(12):726-30. PubMed ID: 6819661
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Californium-252 (252Cf) versus conventional gamma radiation in the brachytherapy of advanced cervical carcinoma long-term treatment results of a randomized study.
    Tacev T; Ptácková B; Strnad V
    Strahlenther Onkol; 2003 Jun; 179(6):377-84. PubMed ID: 12789463
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Phase II study of radiation therapy combined with weekly nedaplatin in locally advanced uterine cervical carcinoma: Kitasato Gynecologic Radiation Oncology Group (KGROG 0501).
    Niibe Y; Hayakawa K; Tsunoda S; Kanai T; Imai M; Arai M; Arai T; Kawaguchi M; Jobo T; Hamada Y; Yago K; Unno N;
    Jpn J Clin Oncol; 2007 Jan; 37(1):70-2. PubMed ID: 17204507
    [TBL] [Abstract][Full Text] [Related]  

  • 39. High-dose rate brachytherapy using inverse planning simulated annealing for locoregionally advanced cervical cancer: a clinical report with 2-year follow-up.
    Kim DH; Wang-Chesebro A; Weinberg V; Pouliot J; Chen LM; Speight J; Littell R; Hsu IC
    Int J Radiat Oncol Biol Phys; 2009 Dec; 75(5):1329-34. PubMed ID: 19409728
    [TBL] [Abstract][Full Text] [Related]  

  • 40. [Radioimmunological diagnosis of endocrine disorders in radiotherapy of cervix carcinoma].
    Modnikov OP
    Radiol Diagn (Berl); 1986; 27(5):643-6. PubMed ID: 3809458
    [No Abstract]   [Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 16.